Decisions of the Unified Patent Court recorded under "Life sciences and pharma" in UPC Litigation Watch, the case law database maintained by Dhenne Avocats.
Decisions of the Unified Patent Court in pharmaceuticals, biotechnology and medical devices: validity and sufficiency, SPCs, generic and biosimilar launches, provisional measures and evidence.
121 decisions recorded
By order of 28 May 2025, the Mannheim Local Division, following a settlement, permitted MED-EL Elektromedizinische Geräte to withdraw its infringement action on EP 4 074 373 against three Advanced Bionics companies (UPC_CFI_410/2023), cancelled the date set for pronouncing the decision and…
In a decision of 13 May 2025 (UPC_CFI_505/2023), the Düsseldorf Local Division considers Regeneron’s EP 3 536 712 B1, which claims a composition comprising a PCSK9 inhibitor for use in reducing lipoprotein(a) (Lp(a)) levels, asserted together with its exclusive licensee Sanofi Biotechnology…
By order of 30 April 2025 (UPC_CoA_768/2024, APL_64374/2024), the Court of Appeal sets aside the Milan Central Division’s order of 22 November 2024 and grants provisional measures against EOFlow, the Korean maker of the EOPatch and GlucoMen Day Pump insulin patch pumps,…
By order of 11 April 2025 (UPC_CFI_597/2024), the Milan Central Division rules on three issues in EOFLOW’s revocation action against Insulet’s EP 4201327, in which Insulet has counterclaimed for infringement.
By order of 10 April 2025 (UPC_CFI_698/2024, ORD_12069/2025), Judge-rapporteur Postiglione (Milan Central Division) granted ALIUD PHARMA, a third party to the action for a declaration of non-infringement of EP 2 501 384 brought by Accord Healthcare against Novartis, access to the statement…
By order of 2 April 2025 (UPC_CFI_18/2025), the judge-rapporteur of the Munich Local Division rejected the preliminary objection of Ascendis, sued by BioMarin for infringement of EP 3 175 863 (variants of C-type natriuretic peptide) in respect of its product TransCon CNP,…
By an order of 15 February 2025 (ORD_65815/2024, UPC_CFI_380/2024), Andrea Postiglione, judge rapporteur in the Milan Central Division, dismissed without examining the substance EOFLOW Co., Ltd.'s application for its costs in the provisional measures proceedings brought by Insulet Corporation on EP 4…
By a common order of 22 January 2025, issued after the preliminary interim conference in Sanofi's four joined infringement actions against Accord, Stada, Reddy and Zentiva (UPC_CFI_145/2024 to UPC_CFI_148/2024, EP 2 493 466, cabazitaxel), the judge-rapporteur of the Munich Local Division (Judge…
By order of 9 January 2025 (UPC_CoA_584/2024), the Court of Appeal disposed of EOFlow’s appeal as devoid of purpose. The appeal challenged the Milan Central Division’s order of 24 September 2024 refusing to join Insulet’s application for provisional measures against EOFlow (EP…
By order of 9 January 2025 (UPC_CoA_769/2024), the judge-rapporteur of the Court of Appeal held that A. Menarini Diagnostics’ confidentiality request in Insulet’s appeal against the Milan Local Division’s refusal of provisional measures (EP 4 201 327) was superfluous.